Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05744960 · ClinicalTrials.gov registry record · NA

Impact of Financial Incentives

A NA study of Human Papilloma Virus, sponsored by UNC Lineberger Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT05744960 is a NA study of Human Papilloma Virus that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 34 participants, below the 623-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05744960, a NA study of Human Papilloma Virus, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.

Conditions Studied

Human Papilloma Virus

Interventions

  • BEHAVIORAL Communication training
  • BEHAVIORAL financial Incentive

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2023-02-28
Est. Completion 2026-08-29
Phase NA

Sponsor

UNC Lineberger Comprehensive Cancer Center

366 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05744960

The ClinicalTrials.gov registry entry for NCT05744960 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 623-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (95% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 2 interventions - of which Communication training is the first listed.

NCT05744960 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05744960 about?

NCT05744960 is a clinical study titled "Impact of Financial Incentives". This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data...

What is the current status of trial NCT05744960?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2023-02-28. Estimated completion is 2026-08-29.

What conditions does trial NCT05744960 study?

This clinical trial studies the following conditions: Human Papilloma Virus.

What interventions are being tested in trial NCT05744960?

The interventions under investigation include: Communication training (BEHAVIORAL), financial Incentive (BEHAVIORAL).

Who is sponsoring clinical trial NCT05744960?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05744960 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Human Papilloma Virus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Human Papilloma Virus

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.